Anti-cancer
Lapatinib
Also known as: Lapatinib Ditosylate
CAS No.
231277-92-2
A dual tyrosine kinase inhibitor (HER2/EGFR) used in oral oncology formulations for HER2-positive breast cancer.
Lapatinib is a targeted dual tyrosine kinase inhibitor oncology API manufactured by NovaAcura Biotech under strict GMP conditions. Full batch documentation and regulatory support are available for global oncology formulation partners.
Applications & Uses
A dual tyrosine kinase inhibitor (HER2/EGFR) used in oral oncology formulations for HER2-positive breast cancer.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch